Changes in Hong Kong stocks | Tianxing Healthcare (01609) rose more than 7%, and overseas revenue increased by more than 70% in the first half of the year, accounting for nearly a quarter

The Zhitong Finance App learned that Tianxing Healthcare (01609) increased by more than 7%, with a cumulative increase of more than 35% during the month. As of press release, it rose 3.25% to HK$159, with a turnover of HK$305.24,700.

According to the news, Tianxing Medical announced interim results. The first half of the year achieved revenue of about RMB 163 million, an increase of 21.6% over the previous year; the adjusted net profit was about 488.97 million yuan, up 24.3% year on year. The increase in profit was mainly due to a sharp increase in sales of core products and effective cost control.

It is worth noting that the company has accelerated its international market expansion strategy. This move has significantly increased overseas market coverage and business scale. Overseas sales revenue during the period was approximately RMB 406.98 million, an increase of 70.6% over the same period in 2025. Overseas revenue increased as a share of total revenue to 24.9%.